119 related articles for article (PubMed ID: 8551410)
1. Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitis.
Ishii E; Yamamoto S; Sakai R; Hamasaki Y; Miyazaki S
J Pediatr; 1996 Jan; 128(1):152-5. PubMed ID: 8551410
[TBL] [Abstract][Full Text] [Related]
2. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis.
Bunikowski R; Gerhold K; Bräutigam M; Hamelmann E; Renz H; Wahn U
Int Arch Allergy Immunol; 2001 Aug; 125(4):344-8. PubMed ID: 11574757
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993.
Camp RD; Reitamo S; Friedmann PS; Ho V; Heule F
Br J Dermatol; 1993 Aug; 129(2):217-20. PubMed ID: 7654593
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases.
Leonardi S; Marchese G; Rotolo N; Miraglia Del Giudice M; La Rosa M
Minerva Pediatr; 2004 Apr; 56(2):231-7. PubMed ID: 15249910
[TBL] [Abstract][Full Text] [Related]
5. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention.
Bottari V; Frezzolini A; Ruffelli M; Puddu P; Fontana L; De Pità O
Allergy; 1999 May; 54(5):507-10. PubMed ID: 10380784
[TBL] [Abstract][Full Text] [Related]
7. [Cyclosporin A in atopic dermatitis: therapeutic effect and effect on allergic reactions are dissociated from each other].
Munro CS; Higgins EM; Marks JM; Daly BM; Friedmann PS; Shuster S
Wien Med Wochenschr; 1991; 141(18-19):419-23. PubMed ID: 1776256
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe atopic dermatitis in childhood with cyclosporin.
Zaki I; Emerson R; Allen BR
Br J Dermatol; 1996 Sep; 135 Suppl 48():21-4. PubMed ID: 8881900
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine in atopic dermatitis. Modulation in the expression of immunologic markers in lesional skin.
van Joost T; Kozel MM; Tank B; Troost R; Prens EP
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):922-8. PubMed ID: 1479097
[TBL] [Abstract][Full Text] [Related]
10. Reduced cytokine production in response to stimulation with dust mite antigen after cyclosporin A treatment of atopic dermatitis.
Kubota Y; Imayama S; Koga T; Hori Y
Exp Dermatol; 1995 Apr; 4(2):117-8. PubMed ID: 7640876
[No Abstract] [Full Text] [Related]
11. An unexpected increase in circulating IFN-gamma by cyclosporin A in atopic patients: a discrepancy between in vitro and in vivo events.
Shiohara T; Sagawa Y; Nagashima M
Acta Derm Venereol; 1994 Jan; 74(1):20-1. PubMed ID: 7908481
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
Harper JI; Ahmed I; Barclay G; Lacour M; Hoeger P; Cork MJ; Finlay AY; Wilson NJ; Graham-Brown RA; Sowden JM; Beard AL; Sumner MJ; Berth-Jones J
Br J Dermatol; 2000 Jan; 142(1):52-8. PubMed ID: 10651694
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A in atopic dermatitis.
Gaig P; Alijotas J; López A; Valencia M; Cisteró A
Allergol Immunopathol (Madr); 1993; 21(5):169-72. PubMed ID: 8160560
[TBL] [Abstract][Full Text] [Related]
14. IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment.
Lucae S; Schmid-Grendelmeier P; Wüthrich B; Kraft D; Valenta R; Linhart B
Allergy; 2016 Jan; 71(1):115-8. PubMed ID: 26234649
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine treatment decreases the percentage of cutaneous lymphocyte antigen (CLA)(+)CD4(+) T cells in children with severe atopic dermatitis.
Lee SY; Shim JY; Kim JH; Kim BS; Seo HJ; Choi SO; Jang SO; Hong SJ
Allergy; 2004 Oct; 59(10):1129-30. PubMed ID: 15355478
[No Abstract] [Full Text] [Related]
16. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis.
Kanda N; Enomoto U; Watanabe S
J Invest Dermatol; 2001 Dec; 117(6):1635-46. PubMed ID: 11886533
[TBL] [Abstract][Full Text] [Related]
17. Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both.
Baumgrass R; Brandt C; Wegner F; Abdollahnia M; Worm M
J Allergy Clin Immunol; 2010 Jul; 126(1):183-4; author reply 184. PubMed ID: 20542321
[No Abstract] [Full Text] [Related]
18. Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study.
Lee SS; Tan AW; Giam YC
Ann Acad Med Singap; 2004 May; 33(3):311-3. PubMed ID: 15175770
[TBL] [Abstract][Full Text] [Related]
19. Can cyclosporin A induce permanent remission of atopic dermatitis?
Sepp N; Fritsch PO
Br J Dermatol; 1993 Feb; 128(2):213-6. PubMed ID: 8457456
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CD11b on eosinophils in atopic dermatitis: downregulation by cyclosporin A and upregulation by interleukin 5.
Yamada H; Kurashimo S; Chihara J; Matsukura M; Yudate T; Tezuka T
Int Arch Allergy Immunol; 1999; 120 Suppl 1():100-3. PubMed ID: 10529615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
